We are live on ! Find out more
PSTV

Plus Therapeutics
PSTV

Delisted

PSTV was delisted on the 31st of July, 2026.

Back to rankings

3 hedge funds and large institutions have $32.1M invested in Plus Therapeutics in 2013 Q2 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

85% less call options, than puts

Call options by funds: $101K | Put options by funds: $687K

Holders
3
Holders Change
+3
Holders Change %
–
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
–
Closed
–
Calls
$101K
Puts
$687K
Net Calls
-$586K
Net Calls Change
-$586K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
51
Rotella Capital Management
Washington
$48K – – –
Goldman Sachs
52
Goldman Sachs
New York
$44K – – –
LPL Financial
53
LPL Financial
California
$44K – – –
T. Rowe Price Associates
54
T. Rowe Price Associates
Maryland
$44K – – –
PC
55
Passport Capital
California
$42K – – –
CS
56
Credit Suisse
Switzerland
$39K – – –
DADC
57
D.A. Davidson & Co
Montana
$39K – – –
RFC
58
Russell Frank Company
Washington
$38K – – –
Hudson Bay Capital Management
59
Hudson Bay Capital Management
Connecticut
$37K – – –
Mitsubishi UFJ Asset Management
60
Mitsubishi UFJ Asset Management
Japan
$34K – – –
Janney Montgomery Scott
61
Janney Montgomery Scott
Pennsylvania
$31.1K – – –
Bank of America
62
Bank of America
North Carolina
$29K – – –
Mariner
63
Mariner
Kansas
$28K – – –
OC
64
Oppenheimer & Co
New York
$28K – – –
TC
65
TFS Capital
Pennsylvania
$28K – – –
Barclays
66
Barclays
United Kingdom
$27K – – –
Citigroup
67
Citigroup
New York
$20K – – –
Ameriprise
68
Ameriprise
Minnesota
$14K – – –
LTFS
69
Ladenburg Thalmann Financial Services
Florida
$5K – – –
MWAM
70
Mariner Wealth Advisors (Madison)
Kansas
$5K – – –
BlackRock
71
BlackRock
New York
$4K – – –
UB
72
UMB Bank
Missouri
$83 – – –
1 2
3

PSTV Hedge Fund Activity: Q2 2013 in Review

3 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q2 2013, worth a combined $32.1M.

Buyers outnumbered sellers: 3 funds opened new PSTV positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.

  • 3 institutional investors held Plus Therapeutics (PSTV) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $32.1M of Plus Therapeutics stock for Q2 2013.
  • 3 funds opened new Plus Therapeutics positions in Q2 2013 and 0 closed out, a net change of +3 holders.

Based on aggregated 13F filings for Q2 2013.